4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000148
EVP & Chief Financial Officer sold 3,298 shares at $500.00 ($1,649,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WAGNER CHARLES F JR · EVP & Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-10 | Sale : show line 1 in the form 10b5-1 | −3,298 | $500.00 | $1,649,000 | 51,671 | D |
| Open-market sales · 3,298 sh · avg $500.00 · $1,649,000 | ||||||
Loading xslF345X05/wk-form4_1741810299.xml…